Search results for "Diabetes"
Diabetes Collaborative Registry seeks primary care participants
ACP has partnered with the American College of Cardiology to recruit primary care practices to participate in the Diabetes Collaborative Registry (DCR).
https://immattersacp.org/weekly/archives/2015/03/31/7.htm
31 Mar 2015
ACP/Annals forum addresses adult vaccinations
Patient hesitation and physician uncertainty are two barriers to achieving optimal vaccination rates, according to expert panelists.
https://immattersacp.org/archives/2024/04/acpannals-forum-addresses-adult-vaccinations.htm
1 Apr 2024
Intensive food-as-medicine program improves engagement, not glycemic control
Patients with diabetes and food insecurity who received healthy groceries, dietitian consults, nurse evaluations, health coaching, and diabetes education had increased engagement with preventive care but no significant change in HbA1c levels versus usual care.
https://immattersacp.org/weekly/archives/2024/01/02/2.htm
2 Jan 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://immattersacp.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023
Basal insulin for beginners
It can be tough to start and titrate basal insulin in a patient with type 2 diabetes because of the many options available, but a key number can measure the difference between a patient's bedtime and morning blood glucose values to ease the way.
https://immattersacp.org/archives/2022/05/basal-insulin-for-beginners.htm
1 May 2022
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://immattersacp.org/weekly/archives/2022/11/08/4.htm
8 Nov 2022
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024